In a new action plan, the White House aims to boost the country’s AI innovation through deregulation, infrastructure ...

In a new analysis, the American Medical Association detailed the lack of competition among pharmacy benefit managers and ...

Health and Human Services Secretary Robert F. Kennedy Jr. is cancelling 22 mRNA vaccine contracts funded by BARDA. Without evidence, Kennedy claimed these vaccines fail to protect effectively against ...

Two U.S. representatives have introduced the Prompt and Fair Pay Act, a bipartisan bill that would require Medicare Advantage ...

HHS Secretary Robert F. Kennedy Jr. is reportedly planning to dismiss all 16 members of the U.S. Preventive Services Task ...

In this episode, we’re joined by Dr. Keith Berkle, chair of Privia Women’s Health, who discusses the challenges OBGYNs face in transitioning to value-based care.

A next-generation Vertex Pharmaceuticals pain drug failed to beat a placebo in a Phase 2 clinical trial. Despite the disappointing outcome in bunionectomy pain, the company is continuing ...

Arbital Health, a health tech company focused on value-based care, has secured $31 million in Series B funding, the company announced last week.

Healthcare doesn’t reward shortcuts. It rewards outcomes. AI will play a critical role in shaping those outcomes — but only if leaders measure what truly matters. The best AI implementations ...

Sudo Bioscience emerged with $37 million in funding and four programs that address TYK2, a promising target for autoimmune diseases. Bristol Myers Squibb drug Sotyktu recently won the first FDA ...